Triamcinolone - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for triamcinolone and what is the scope of patent protection?
Triamcinolone
is the generic ingredient in thirty-one branded drugs marketed by Astellas, Delcor Asset Corp, Barr, Impax Labs, Ivax Sub Teva Pharms, Mylan, Purepac Pharm, Roxane, Sandoz, Teva, Watson Labs, Abbvie, Chattem Sanofi, Ivax Pharms, Solvay, Actavis Mid Atlantic, Alkem Labs Ltd, Alpharma Us Pharms, Ambix, Chartwell Rx, Cosette, Encube, Fougera Pharms, Glenmark Pharms Ltd, Macleods Pharms Ltd, Micro Labs, Morton Grove, Norvium Bioscience, Padagis Us, Pharmaderm, Pharmafair, Strides Pharma, Taro, Topiderm, Crown Labs, Savage Labs, Pacira Pharms Inc, Apothecon, Amneal, Eugia Pharma, Long Grove Pharms, Mylan Labs Ltd, Parnell, Teva Pharms Usa, Allergan, Harrow Eye, Epic Pharma Llc, Pai Holdings Pharm, Quagen, Wockhardt Bio Ag, Aurobindo Pharma Ltd, Cintex Svcs, Extrovis, Glenmark Speclt, Padagis Israel, Cmp Pharma Inc, Lyne, Sciegen Pharms Inc, Lupin Atlantis, Sanofi Aventis Us, Apotex, Perrigo Pharma Intl, Sun Pharm Inds Inc, Rising, Bausch And Lomb Inc, and Fosun Pharma, and is included in one hundred and sixty-seven NDAs. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.There are fifty-one drug master file entries for triamcinolone.
Summary for triamcinolone
| US Patents: | 7 |
| Tradenames: | 31 |
| Applicants: | 66 |
| NDAs: | 167 |
| Drug Master File Entries: | 51 |
| Raw Ingredient (Bulk) Api Vendors: | 76 |
| Clinical Trials: | 407 |
| Patent Applications: | 6,787 |
| Drug Prices: | Drug price trends for triamcinolone |
| Drug Sales Revenues: | Drug sales revenues for triamcinolone |
| DailyMed Link: | triamcinolone at DailyMed |
Recent Clinical Trials for triamcinolone
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| David Sheyn | Phase 2/Phase 3 |
| Ain Shams University | Phase 3 |
| Tanta University | N/A |
Medical Subject Heading (MeSH) Categories for triamcinolone
Anatomical Therapeutic Chemical (ATC) Classes for triamcinolone
US Patents and Regulatory Information for triamcinolone
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Padagis Us | TRIAMCINOLONE ACETONIDE | triamcinolone acetonide | OINTMENT;TOPICAL | 087385-001 | Approved Prior to Jan 1, 1982 | AT | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Taro | TRIAMCINOLONE ACETONIDE | triamcinolone acetonide | OINTMENT;TOPICAL | 040386-001 | Jun 5, 2001 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Chattem Sanofi | NASACORT ALLERGY 24 HOUR | triamcinolone acetonide | SPRAY, METERED;NASAL | 020468-002 | Oct 11, 2013 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Morton Grove | TRIAMCINOLONE ACETONIDE | triamcinolone acetonide | OINTMENT;TOPICAL | 088090-001 | Sep 1, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Fosun Pharma | ARISTOCORT | triamcinolone diacetate | INJECTABLE;INJECTION | 011685-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Delcor Asset Corp | KENALOG | triamcinolone acetonide | LOTION;TOPICAL | 011602-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pharmaderm | TRIAMCINOLONE ACETONIDE | triamcinolone acetonide | CREAM;TOPICAL | 087991-001 | Jul 7, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
